544 related articles for article (PubMed ID: 23338682)
1. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
[TBL] [Abstract][Full Text] [Related]
2. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.
Galimberti D; Fenoglio C; Serpente M; Villa C; Bonsi R; Arighi A; Fumagalli GG; Del Bo R; Bruni AC; Anfossi M; Clodomiro A; Cupidi C; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Bessi V; Marcone A; Cerami C; Cappa SF; Filippi M; Agosta F; Magnani G; Comi G; Franceschi M; Rainero I; Giordana MT; Rubino E; Ferrero P; Rogaeva E; Xi Z; Confaloni A; Piscopo P; Bruno G; Talarico G; Cagnin A; Clerici F; Dell'Osso B; Comi GP; Altamura AC; Mariani C; Scarpini E
Biol Psychiatry; 2013 Sep; 74(5):384-91. PubMed ID: 23473366
[TBL] [Abstract][Full Text] [Related]
5. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
[TBL] [Abstract][Full Text] [Related]
6. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study.
Benussi L; Rossi G; Glionna M; Tonoli E; Piccoli E; Fostinelli S; Paterlini A; Flocco R; Albani D; Pantieri R; Cereda C; Forloni G; Tagliavini F; Binetti G; Ghidoni R
J Alzheimers Dis; 2014; 38(4):799-808. PubMed ID: 24064469
[TBL] [Abstract][Full Text] [Related]
7. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
8. Differences in Motor Features of
Tipton PW; Deutschlaender AB; Savica R; Heckman MG; Brushaber DE; Dickerson BC; Gavrilova RH; Geschwind DH; Ghoshal N; Graff-Radford J; Graff-Radford NR; Grossman M; Hsiung GR; Huey ED; Irwin DJ; Jones DT; Knopman DS; McGinnis SM; Rademakers R; Ramos EM; Forsberg LK; Heuer HW; Onyike C; Tartaglia C; Domoto-Reilly K; Roberson ED; Mendez MF; Litvan I; Appleby BS; Grant I; Kaufer D; Boxer AL; Rosen HJ; Boeve BF; Wszolek ZK;
Neurology; 2022 Sep; 99(11):e1154-e1167. PubMed ID: 35790423
[TBL] [Abstract][Full Text] [Related]
9. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
10. Co-occurrence of the C9ORF72 expansion and a novel GRN mutation in a family with alternative expression of frontotemporal dementia and amyotrophic lateral sclerosis.
Testi S; Tamburin S; Zanette G; Fabrizi GM
J Alzheimers Dis; 2015; 44(1):49-56. PubMed ID: 25182743
[TBL] [Abstract][Full Text] [Related]
11. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.
Wood EM; Falcone D; Suh E; Irwin DJ; Chen-Plotkin AS; Lee EB; Xie SX; Van Deerlin VM; Grossman M
JAMA Neurol; 2013 Nov; 70(11):1411-7. PubMed ID: 24081456
[TBL] [Abstract][Full Text] [Related]
13. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
[TBL] [Abstract][Full Text] [Related]
15. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS
Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.
Van Langenhove T; van der Zee J; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Mattheijssens M; Peeters K; Nuytten D; Cras P; De Deyn PP; De Jonghe P; Cruts M; Van Broeckhoven C
Neurobiol Aging; 2012 May; 33(5):1004.e17-20. PubMed ID: 22035589
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
20. Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.
Debray S; Race V; Crabbé V; Herdewyn S; Matthijs G; Goris A; Dubois B; Thijs V; Robberecht W; Van Damme P
Neurobiol Aging; 2013 Dec; 34(12):2890.e7-2890.e12. PubMed ID: 23870417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
